Trial Profile
A double blind, randomized, placebo controlled, cross-over, Lybridos dose finding study to validate the predictive power of the diagnostic model for Lybrido and Lybridos efficacy and to identify and evaluate additional psychometric and biological markers which increase the predictive power of the diagnostic model, in women with hypoactive sexual desire disorder with or without sexual arousal disorder and/or female orgasmic disorder or SSRI induced sexual dysfunction, in the domestic situation.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2014
Price :
$35
*
At a glance
- Drugs Buspirone/testosterone (Primary) ; Sildenafil/testosterone (Primary)
- Indications Decreased libido; Female sexual dysfunction
- Focus Therapeutic Use
- Acronyms @home
- Sponsors Companion Diagnostics BV
- 08 Apr 2014 New source identified and integrated (Netherlands Trial Register; NTR4426)
- 08 Apr 2014 New trial record